ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,052,046 | -13.9% | 448,582 | -2.5% | 0.00% | 0.0% |
| Q2 2023 | $9,347,069 | +7.1% | 460,220 | -3.8% | 0.00% | 0.0% |
| Q1 2023 | $8,726,016 | -13.6% | 478,400 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $10,101,167 | -18.0% | 488,451 | +3.8% | 0.00% | -33.3% |
| Q3 2022 | $12,313,000 | +14.8% | 470,696 | +11.2% | 0.00% | +50.0% |
| Q2 2022 | $10,730,000 | +61.3% | 423,449 | +100.8% | 0.00% | +100.0% |
| Q1 2022 | $6,654,000 | -31.5% | 210,835 | -12.2% | 0.00% | -50.0% |
| Q4 2021 | $9,716,000 | +26.4% | 240,064 | +8.9% | 0.00% | +100.0% |
| Q3 2021 | $7,685,000 | +37.6% | 220,393 | +8.3% | 0.00% | 0.0% |
| Q2 2021 | $5,586,000 | +17.2% | 203,411 | +19.8% | 0.00% | 0.0% |
| Q1 2021 | $4,767,000 | +0.6% | 169,749 | -7.0% | 0.00% | 0.0% |
| Q4 2020 | $4,739,000 | +68.9% | 182,563 | +11.6% | 0.00% | 0.0% |
| Q3 2020 | $2,805,000 | -33.1% | 163,597 | -3.4% | 0.00% | 0.0% |
| Q2 2020 | $4,190,000 | +102.3% | 169,391 | +13.5% | 0.00% | 0.0% |
| Q1 2020 | $2,071,000 | +64.0% | 149,244 | +19.3% | 0.00% | – |
| Q4 2019 | $1,263,000 | +11.2% | 125,065 | +0.1% | 0.00% | – |
| Q3 2019 | $1,136,000 | +22.2% | 124,924 | +6.8% | 0.00% | – |
| Q2 2019 | $930,000 | -30.4% | 116,983 | +9.3% | 0.00% | – |
| Q1 2019 | $1,336,000 | +23.7% | 107,003 | +6.8% | 0.00% | – |
| Q4 2018 | $1,080,000 | +266.1% | 100,237 | +373.2% | 0.00% | – |
| Q3 2018 | $295,000 | +50.5% | 21,185 | +32.0% | 0.00% | – |
| Q2 2018 | $196,000 | – | 16,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |